Biology of nitric oxide signaling

Critical Care Medicine

Volumn 28, Issue 4 SUPPL., 2000, Pages

  Liaudet, Lucas ^c   Soriano, Francisco Garcia ^b   Szabó, Csaba ^a,b  

^a INOTEK CORPORATION   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Cell signaling; Cytotoxicity; Dinitrogen trioxide; Nitration; Nitric oxide; Nitrosation; Nitrosothiols; Oxidation; Peroxynititee; Superoxide radical

Indexed keywords

ANTIOXIDANT; FREE RADICAL; NITRIC OXIDE; NITROGEN DIOXIDE; PEROXYNITRITE; SUPEROXIDE;

CELL PROTECTION; CYTOTOXICITY; HUMAN; INFLAMMATION; ISCHEMIA; NITROSATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SECOND MESSENGER; SHOCK; SIGNAL TRANSDUCTION;

EID: 0034059625     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200004001-00005     Document Type: Review

References (278)

1. Nathan C, Xie QW: Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915-918
2. Szabo C: Alterations in nitric oxide production in various forms of circulatory shcok. New Horizons 1995; 3:2-32
3. Lane P, Gross SS: Cell signaling by nitric oxide. Semin Nephrol 1999; 19:215-229
4. Patel RP, McAndrew J, Sellak H, et al: Biological aspects of reactive nitrogen species. Biochim Biophys Acta 1999; 1411:385-400
5. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996; 271: C1424-C1437
6. Wink DA, Mitchell JB: Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998; 25: 434-456
7. Grisham MB, Jourd'Heuil D, Wink DA: Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites:implications in inflammation. Am J Physiol 1999; 276: G315-G321
8. Stuehr DJ: Mammalian nitric oxide synthases. Biochim Biophys Acta 1999; 1411: 217-230
9. Michel T, Feron O: Nitric oxide synthases: Which, where, how, and why? J Clin Invest 1997; 100:2146-2152
10. Miller MJ, Sandoval M: Nitric Oxide. III. A molecular prelude to intestinal inflammation. Am J Physiol 1999; 276:G795-G799
11. Cooper CE: Nitric oxide and iron proteins. Biochim Biophys Acta 1999; 1411:290-309
12. Murad F: Nitric oxide signaling: would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone? Recent Prog Horm Res 1998; 53:43-59
13. Denninger JW, Marietta MA: Guanylate cyclase and the .NO/cGMP signaling pathway. Biochim Biophys Acta 1999; 1411:334-350
14. Schmidt HH, Walter U: NO at work. Cell 1994; 78:919-925
15. Marin J, Rodriguez-Martinez MA: Role of vascular nitric oxide in physiological and pathological conditions. Pharmacol Ther 1997; 75:111-134
16. Zagotta WN, Siegelbaum SA: Structure and function of cyclic nucleotide-gated channels. Annu Rev Neurosci 1996; 19:235-263
17. Salvemini D: Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol Life Sci 1997; 53:576-582
18. Salvemini D, Misko TP, Masferrer JL, et al: Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993; 90:7240-7244
19. Salvemini D, Seibert K, Masferrer JL, et al: Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest 1994; 93: 1940-1947
20. Corbett JA, Kwon G, Turk J,35 al: IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: Activation of cyclooxygenase by nitric oxide. Biochem 1993; 32: 13767-13770
21. Davidge ST, Baker PN, Laughlin MK, et al: Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 1995; 77:274-283
22. Kanner J, Harel S, Granit R: Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 1992; 27:46-49
23. Stadler J, Harbrecht BG, Di Silvio M, et al: Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol 1993; 53:165-172
24. Tsai AL, Wei C, Kulmacz RJ: Interaction between nitric oxide and prostaglandin H synthase. Arch Biochem Biophys 1994; 313: 367-372
25. 2 isomerase activity by PDGF: involvement of nitric oxide. Arch Biochem Biophys 1994; 312:240-243
26. Zou M, Yesilkaya A, Ullrich V: Peroxynitrite inactivates prostacyclin synthase by hemethiolate-catalyzed tyrosine nitration. Drug Metab Rev 1999; 31:343-349
27. Grisham MB, Granger DN, Lefer DJ: Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: Relevance to ischemic heart disease. Free Radic Biol Med 1998; 25:404-433
28. Veihelmann A, Brill T, Blobner M, et al: Inhibition of nitric oxide synthesis improves detoxication in inflammatory liver dysfunction in vivo. Am J Physiol 1997; 273:G530-G536
29. Takemura S, Minamiyama Y, Imaoka S, et al: Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia. J Hepatol 1999; 30:1035-1044
30. Alonso-Galicia M, Drummond HA, Reddy KK, et al: Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension 1997; 29:320-325
31. Muller CM, Scierka A, Stiller RL, et al: Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin. Anesthesiology 1996; 84:1435-1442
32. Vickroy TW, Malphurs WL: Inhibition of nitric oxide synthase activity in cerebral cortical synaptosomes by nitric oxide donors: Evidence for feedback autoregulation. Neurochem Res 1995; 20:299-304
33. Griscavage JM, Hobbs AJ, Ignarro LJ: Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds. Adv Pharmacol 1995; 34:215-234
34. Rengasamy A, Johns RA: Regulation of nitric oxide synthase by nitric oxide. Mol Pharmacol 1993; 44:124-128
35. Hyun J, Komori Y, Chaudhuri G, et al: The protective effect of tetrahydrobiopterin on the nitric oxide-mediated inhibition of purified nitric oxide synthase. Biochem Biophys Res Commun 1995; 206:380-386
36. Schwartz D, Mendonca M, Schwartz I, et al: Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 1997; 100:439-448
37. Szabo C, Bryk R, Zingarelli B, et al: Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform. Br J Pharmacol 1996; 118:1659-1668
38. Kessler P, Popp R, Busse R, et al: Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism. Circulation 1999; 99:1878-1884
39. Hoshino M, Ozawa K, Seki H, et al: Photochemistry of nitric oxide adducts of water-soluble iron(III) porphyrin and ferrihemoproteins studie by nanosecond laser photolysis. J Am Chem Soc 1993; 115: 9568-9575
40. Farias-Eisner R, Chaudhuri G, Aeberhard E, et al:The chemistry and tumoricidal activity of nitric oxide/hydrogen peroxide and the implications to cell resistance/susceptibility. J Biol Chem 1996; 271:6144-6151
41. Smith AW, Green J, Eden CE, et al: Nitric oxide-induced potentiation of the killing of Burkholderia cepacia by reactive oxygen species: implications for cystic fibrosis. J Med Microbiol 1999; 48:419-423
42. Mohazzab HK, Fayngersh RP, Wolin MS: Nitric oxide inhibits pulmonary artery catalase and H202-associated relaxation. Am J Physiol 1996; 271:H1900-H1916
43. Brown GC: Reversible binding and inhibition of catalase by nitric oxide. Eur J Biochem 1995; 232:188-191
44. Brown GC, Cooper CE: Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 1994; 356:295-298
45. Brown GC: Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1999; 1411:351-369
46. Cleeter MW, Cooper JM, Darley-Usmar VM, et al: Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994; 345:50-54
47. Schweizer M, Richter C: Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem Biophys Res Commun 1994; 204:169-175
48. Takehara Y, Kanno T, Yoshioka T, et al: Oxygen-dependent regulation of mitochondrial energy metabolism by nitric oxide. Arch Biochem Biophys 1995; 323:27-32
49. Nishikawa M, Sato EF, Kuroki T, et al: Role of glutathione and nitric oxide in the energy metabolism of rat liver mitochondria. FEBS Lett 1997; 415:341-345
50. Shen W, Hintze TH, Wolin MS: Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 1995; 92:3505-3512
51. Shen W, Xu X, Ochoa M, et al: Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res 1994; 75: 1086-1095
52. Laycock SK, Vogel T, Forfia PR, et al: Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res 1998; 82: 1263-1271
53. 2 uptake after inhibition of EDRF/NO synthesis. J Appl Physiol 1994; 76:1166-1171
54. Ishibashi Y, Duncker DJ, Zhang J, et al: ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circ Res 1998; 82:346-359.
55. Bates TE, Loesch A, Burnstock G, et al: Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation? Biochem Biophys Res Commun 1996; 218:40-44
56. Gross SS, Lane P: Physiological reactions of nitric oxide and hemoglobin: a radical rethink. Proc Natl Acad Sci U S A 1999; 96: 9967-9969
57. Alayash AI: Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants? Nat Biotechnol 1999; 17:545-549
58. Gow AJ, Luchsinger BP, Pawloski JR, et al: The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci U S A 1999; 96: 9027-9032
59. Heyman SN, Goldfarb M, Darmon D, et al: Tissue oxygenation modifies nitric oxide bioavailability. Microcirculation 1999; 6:199-203
60. Kosaka H: Nitric oxide and hemoglobin interactions in the vasculature. Biochim Biophys Acta 1999; 1411:370-377
61. Stamler JS, Jia L, Eu JP, et al: Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 1997; 276:2034-2037
62. Jourd'heuil D, Mills L, Miles AM, et al: Effect of nitric oxide on hemoprotein-catalyzed oxidative reactions. Nitric Oxide 1998; 2:37-44
63. Miles AM, Bohle DS, Glassbrenner PA, et al: Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 1996; 271:40-47
64. Kanner J, Harel S, Granit R: Nitric oxide as an antioxidant. Arch Biochem Biophys 1991; 289:130-136
65. Gardner PR, Costantino G, Szabó C, et al: Nitric oxide sensitivity of the aconitases. J Biol Chem 1997; 272:25071-25076
66. Hentze MW, Kuhn LC: Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 1996; 93:8175-8182
67. Klausner RD, Rouault TA, Harford JB: Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 1993; 72: 19-28
68. Guittet O, Roy B, Lepoivre M: Nitric oxide: A radical molecule in quest of free radicals in proteins. Cell Mol Life Sci 1999; 55: 1054-1067
69. Lepoivre M, Flaman JM, Bobe P, et al: Quenching of the tyrosyl free radical of ribonucleotide redurtase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages. J Biol Chem 1994; 269:21891-21897
70. Hogg N, Kalyanaraman B: Nitric oxide and lipid peroxidation. Biochim Biophys Acta 1999; 1411:378-384
71. Atkinson R, Aschmann SM, Pitts JN: Alkyl nitrate formation from the NOx-air photooxidantions of C2-C8 n-alkanes. J Phys Chem 1982; 86:4563-4587
72. Hogg N, Struck A, Goss SP, et al: Inhibition of macrophage-dependent low density lipoprotein oxidation by nitric-oxide donors. J Lipid Res 1995; 36:1756-1762
73. Malo-Ranta U, Yla-Herttuala S, Metsa-Ketela T, et al: Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett 1994; 337:179-183
74. Liu X, Miller MJS, Joshi MS, et al: Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci U S A 1998; 95:2175-2179
75. Hecht SS: Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis. Proc Soc Exp Biol Med 1997; 216:181-191
76. Gordge MP, Addis P, Noronha-Dutra AA, et al: Cell-mediated biotransformation of S-nitrosoglutathione. Biochem Pharmacol 1998; 55:657-665
77. Kashiba M, Kasahara E, Chien KC, et al: Fates and vascular action of S-nitrosoglutathione and related compounds in the circulation. Arch Biochem Biophys 1999; 363: 213-218
78. Broillet MC: S-nitrosylation of proteins. Cell Mol Life Sci 1999; 55:1036-1042
79. Butler AR, Rhodes P: Chemistry, analysis, and biological roles of S-nitrosothiols. Anal Biochem 1997; 249:1-9
80. Stamler JS, Jaraki O, Osborne J, et al: Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A 1992; 89:7674-7677
81. Jia L, Bonaventura C, Bonaventura J, et al: S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380:221-226
82. Hirayama A, Noronha-Dutra AA, Gordge MP, et al: S-nitrosothiols are stored by platelets and released during platelet-neutrophil interactions. Nitric Oxide 1999; 3:95-104
83. Stubauer G, Giuffre A, Sarti P: Mechanism of S-nitrosothiol formation and degradation mediated by copper ions. J Biol Chem 1999; 274:28128-28133
84. Liu Z, Rudd MA, Freedman JE, Loscalzo J: S-Transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide. J Pharmacol Exp Ther 1998; 284:526-534
85. Lei SZ, Pan ZH, Aggarwal SK, et al: Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 1992; 8:1087-1099
86. Lipton SA, Choi YB, Sucher NJ, et al: Neuroprotective versus neurodestructive effects of NO-related species. Biofactors 1998; 8:33-40
87. Sattler R, Xiong Z, Lu WY, et al: Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 1999; 284:1845-1848
88. Yamauchi M, Omote K, Ninomiya T: Direct evidence for the role of nitric oxide on the glutamate-induced neuronal death in cultured cortical neurons. Brain Res 1998; 780:253-259
89. Galigniana MD, Piwien-Pilipuk G, Assreuy J: Inhibition of glucocorticoid receptor binding by nitric oxide. Mol Pharmacol 1999; 55:317-323
90. Bolotina VM, Najibi S, Palacino JJ, et al: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994; 368:850-853
91. Xu L, Eu JP, Meissner G, Stamler JS: Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 1998; 279:234-237
92. Stoyanovsky D, Murphy T, Anno PR, et al: Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 1997; 21: 19-29
93. Campbell DL, Stamler JS, Strauss HC: Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 1996; 108: 277-293
94. Hu H, Chiamvimonvat N, Yamagishi T, et al: Direct inhibition of expressed cardiac L-type Ca2+ channels by S-nitrosothiol nitric oxide donors. Circ Res 1997; 81: 742-752
95. Arstall MA, Bailey C, Gross WL, et al: Reversible S-nitrosation of creatine kinase by nitric oxide in adult rat ventricular myocytes. J Mol Cell Cardiol 1998; 30:979-988
96. Kaasik A, Minajeva A, De Sousa E, et al: Nitric oxide inhibits cardiac energy production via inhibition of mitochondrial creatine kinase. FEBS Lett 1999; 444:75-77
97. Molina y Vedia L, McDonald B, Reep B, et al: Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation [published erratum appears in J Biol Chem 1993; 268: 3016]. J Biol Chem 1992; 267:24929-24932
98. Mohr S, Hallak H, de Boitte A, et al: Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 1999; 274: 9427-9430
99. Dimmeler S, Brune B: Characterization of a nitric-oxide-catalysed ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Eur J Biochem 1992; 210:305-310
100. Mohr S, Stamler JS, Brune B: Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment. J Biol Chem 1996; 271:4209-4214
101. Schuppe-Koistinen I, Moldeus P, Bergman T, et al: S-thiolation of human endothelial cell glyceraldehyde-3-phosphate dehydrogenase after hydrogen peroxide treatment. Eur J Biochem 1994; 221:1033-1037
102. Gergel D, Cederbaum AI: Inhibition of the catalytic activity of alcohol dehydrogenase by nitric oxide is associated with S nitrosylation and the release of zinc. Biochem 1996; 35:16186-16194
103. Bauer PM, Fukuto JM, Buga GM, et al: Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation. Biochem Biophys Res Commun 1999; 262:355-358
104. Gopalakrishna R, Chen ZH, Gundimeda U: Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J Biol Chem 1993; 268:27180-185
105. Toker A: Signaling through protein kinase C. Front Biosci 1998; 3:D1134-D1147
106. Shizukuda Y, Tang S, Yokota R, et al: Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase C delta activity. Circ Res 1999; 85:247-256
107. Yoshida K, Mizukami Y, Kitakaze M: Nitric oxide mediates protein kinase C isoform translocation in rat heart during postischemic reperfusion. Biochim Biophys Acta 1999; 1453:230-238
108. Toyoshima T, Kamijo R, Takizawa K, et al: Nitric oxide up-regulates the expression of intercellular adhesion molecule-1 on cancer cells. Biochem Biophys Res Commun 1999; 257:395-399
109. Ping P, Takano H, Zhang J, et al: Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: A signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res 1999; 84:587-604
110. Beauchamp P, Richard V, Tamion F, et al.: Protective effects of preconditioning in cultured rat endothelial cells: effects on neutrophil adhesion and expression of ICAM-1 after anoxia and reoxygenation. Circulation 1999; 100:541-6.
111. Gaston B: Nitric oxide and thiol groups. Biochim Biophys Acta 1999; 1411:323-333
112. Lander HM, Sehajpal PK, Novogrodsky A: Nitric oxide signaling: A possible role for G proteins. J Immunol 1993; 151:7182-7187
113. Lander HM, Ogiste JS, Pearce SF, et al: Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J Biol Chem 1995; 270: 7017-7020
114. Lander HM, Hajjar DP, Hempstead BL, et al: A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J Biol Chem 1997; 272:4323-4326
115. Miyamoto A, Laufs U, Pardo C, et al: Modulation of bradykinin receptor ligand binding affinity and its coupled G-proteins by nitric oxide. J Biol Chem 1997; 272:19601-19608
116. Hess DT, Lin LH, Freeman JA, et al: Modification of cysteine residues within G(o) and other neuronal proteins by exposure to nitric oxide. Neuropharmacology 1994; 33: 1283-1292
117. Jumrussirikul P, Dinerman J, Dawson TM, et al: Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. J Clin Invest 1998; 102:1279-1285
118. Akhand AA, Pu M, Senga T, et al: Nitric oxide controls src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism. J Biol Chem 1999; 274: 25821-25826
119. Lander HM, Sehajpal P, Levine DM, et al: Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol 1993; 150: 1509-1516
120. McVey M, Hill J, Howlett A, et al: Adenylyl cyclase, a coincidence detector for nitric oxide. J Biol Chem 1999; 274:18887-18892
121. Vila-Petroff MG, Younes A, Egan J, et al: Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 1999; 84: 1020-1031
122. Peng HB, Libby P, Liao JK: Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 1995; 270:14214-14219
123. Katsuyama K, Shichiri M, Marumo F, et al: NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha. Arterioscler Thromb Vasc Biol 1998; 18:1796-1802
124. DelaTorre A, Schroeder RA, Kuo PC: Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation. Biochem Biophys Res Commun 1997; 238:703-706
125. delaTorre A, Schroeder RA, Bartlett ST, et al: Differential effects of nitric oxide-mediated S-nitrosylation on p50 and c-jun DNA binding. Surgery 1998; 124:137-142
126. delaTorre A, Schroeder RA, Punzalan C, et al: Endotoxin-mediated S-nitrosylation of p50 alters NF-kappa B-dependent gene transcription in ANA-1 murine macrophages. J Immunol 1999; 162:4101-4108
127. Matthews JR, Bolting CH, Panico M, et al: Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res 1996; 24: 2236-2242
128. Raychaudhuri B, Dweik R, Connors MJ, et al: Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages. Am J Respir Cell Mol Biol 1999; 21:311-316
129. Shin WS, Hong YH, Peng HB, et al: Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma. The role of constitutive NF-kappa B activity. J Biol Chem 1996; 271:11317-11324
130. Spiecker M, Darius H, Kaboth K, et al: Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol 1998; 63:732-739
131. De Caterina R, Libby P, Peng HB, et al: Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96:60-68
132. Walley KR, McDonald TE, Higashimoto Y, et al: Modulation of proinflammatory cytokines by nitric oxide in murine acute lung injury. Am J Respir Crit Care Med 1999; 160:698-704
133. Tabuchi A, Sano K, Oh E, et al: Modulation of AP-1 activity by nitric oxide (NO) in vitro: NO-mediated modulation of AP-1. FEBS Lett 1994; 351:123-127
134. Klatt P, Molina EP, Lamas S: Nitric oxide inhibits c-Jun DNA binding by specifically targeted S-glutathionylation. J Biol Chem 1999; 274:15857-15864
135. Murphy MP: Nitric oxide and cell death. Biochim Biophys Acta 1999; 1411:401-414
136. Brendeford EM, Andersson KB, Gabrielsen OS: Nitric oxide (NO) disrupts specific DNA binding of the transcription factor c-Myb in vitro. FEBS Lett 1998; 425:52-56
137. Rodriguez-Ariza A, Paine AJ: Rapid induction of NF-kappaB binding during liver cell isolation and culture: Inhibition by L-NAME indicates a role for nitric oxide synthase. Biochem Biophys Res Commun 1999; 257:145-148
138. Simpson CS, Morris BJ: Activation of nuclear factor kappaB by nitric oxide in rat striatal neurones: differential inhibition of the p50 and p65 subunits by dexamethasone. J Neurochem 1999; 73:353-361
139. Hierholzer C, Harbrecht B, Menezes JM, et al: Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 1998; 187:917-928
140. Xuan YT, Tang XL, Banerjee S, et al: Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res 1999; 84:1095-1109
141. Walker MW, Kinter MT, Roberts RJ, et al: Nitric oxide-induced cytotoxicity: involvement of cellular resistance to oxidative stress and the role of glutathione in protection. Pediatr Res 1995; 37:41-49
142. Petit JF, Nicaise M, Lepoivre M, et al: Protection by glutathione against the antiproliferative effects of nitric oxide. Dependence on kinetics of no release. Biochem Pharmacol 1996; 52:205-212
143. Clark AG, Debnam P: Inhibition of glutathione S-transferases from rat liver by S-nitroso-L-glutathione. Biochem Pharmacol 1988; 37:3199-3201
144. Becker K, Gui M, Schirmer RH: Inhibition of human glutathione reductase by S-nitrosoglutathione. Eur J Biochem 1995; 234:472-478
145. Han J, Stamler JS, Li HL, et al: Inhibition of g-glutamylcysteine synthetase by S-nitrosylation. In: Biology of Nitric Oxide. Vol. IV. Stamler JS, Moncada S, Higgs A (Eds). London, Portland Press, 1996, p 114
146. Clancy RM, Levartovsky D, Leszczynska-Piziak J, et al: Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: Evidence for S-nitrosoglutathione as a bioactive intermediary. Proc Natl Acad Sci U S A 1994; 91:3680-3684
147. Moellering D, McAndrew J, Patel RP, et al: The induction of GSH synthesis by nanomolar concentrations of NO in endothelial cells: A role for gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase. FEBS Lett 1999; 448:292-296
148. Li H, Marshall ZM, Whorton AR: Stimulation of cystine uptake by nitric oxide: regulation of endothelial cell glutathione levels. Am J Physiol 1999; 276:C803-C811
149. Koppenol WH: The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radic Biol Med 1998; 25:385-391
150. Squadrito GL, Pryor WA: Oxidative chemistry of nitric oxide: The roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med 1998; 25:392-403
151. Uppu RM, Squadrito GL, Pryor WA: Acceleration of peroxynitrite oxidations by carbon dioxide. Arch Biochem Biophys 1996; 327:335-343
152. Lymar SV, Jiang Q, Hurst JK: Mechanism of carbon dioxide-catalyzed oxidation of tyrosine by peroxynitrite. Biochemistry 1996; 35:7855-7861
153. Denicola A, Freeman BA, Trujillo M, et al: Peroxynitrite reaction with carbon dioxide/ bicarbonate: kinetics and influence on peroxynitrite-mediated oxidations. Arch Biochem Biophys 1996; 333:49-58
154. Brandes RP, Koddenberg G, Gwinner W, et al: Role of increased production of superoxide anions by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia. Hypertension 1999; 33:1243-1249
155. Nohl H: Generation of superoxide radicals as byproduct of cellular respiration. Ann Biol Clin 1994; 52:199-204
156. Kroncke KD, Fehsel K, Kolb-Bachofen V: Nitric oxide: cytotoxicity versus cytoprotection - How, why, when, and where? Nitric Oxide 1997; 1:107-120
157. Xia Y, Dawson VL, Dawson TM, et al: Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A 1996; 93: 6770-6774
158. Xia Y, Zweier JL: Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A 1997; 94:6954-6958
159. Darley-Usmar VM, Hogg N, O'Leary VJ, et al: The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun 1992; 17: 9-20
160. Vasquez-Vivar J, Martasek P, Hogg N, et al: Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry 1997; 36:11293-11297
161. Beckman JS, Chen J, Ischiropoulos H, et al: Oxidative chemistry of peroxynitrite. Methods Enzymol 1994; 233:229-240
162. Koppenol WH, Moreno JJ, Pryor WA, et al: Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 1992; 5:834-842
163. Rubbo H, Radi R, Trujillo M, et al: Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994; 269:26066-26075
164. Stralin P, Karlsson K, Johansson BO, et al: The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 1995; 15:2032-2036
165. Villa LM, Salas E, Darley-Usmar VM, et al: Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci U S A 1994; 91:12383-12387
166. Brown AS, Moro MA, Masse JM, et al: Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite. Cardiovasc Res 1998; 40:380-388
167. Lefer DJ, Scalia R, Campbell B, et al: Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 1997; 99:684-691
168. Moro MA, Darley-Usmar VM, Lizasoain I, et al: The formation of nitric oxide donors from peroxynitrite. Br J Pharmacol 1995; 116:1999-2004
169. Dowell FJ, Martin W: The effects of peroxynitrite on rat aorta: interaction with glucose and related substances. Eur J Pharmacol 1997; 338:43-53
170. Wu M, Pritchard KA Jr, Kaminski PM, et al: Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxynitrite. Am J Physiol 1994; 266: H2108-H2113
171. Tarpey MM, Beckman JS, Ischiropoulos H, et al: Peroxynitrite stimulates vascular smooth muscle cell cyclic GMP synthesis. FEBS Lett 1995; 364:314-318
172. Mayer B, Schrammel A, Kiatt P, et al: Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase. Dependence on glutathione and possible role of S-nitrosation. J Biol Chem 1995; 270: 17355-17360
173. Wei EP, Kontos HA, Beckman JS: Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite. Am J Physiol 1996; 271:H1262-H1266
174. Brahn E, Banquerigo ML, Firestein GS, et al: Collagen induced arthritis: Reversal by mercaptoethylguanidine, a novel antiinflammatory agent with a combined mechanism of action. J Rheumatol 1998; 25: 1785-1793
175. Cuzzocrea S, Zingarelli B, Gilad E, et al: Protective effect of melatonin in carrageenan-induced models of local inflammation: Relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J Pineal Res 1997; 23: 106-116
176. Zingarelli B, Cuzzocrea S, Szabo C, et al: Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther 1998; 287: 1048-1055
177. Endres M, Scott G, Namura S, et al: Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemia-reperfusion. Neurosci Lett 1998; 248:41-44
178. Cuzzocrea S, Zingarelli B, Costantino G, et al: Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol 1997; 121:1065-1074
179. Zingarelli B, Day BJ, Crapo JD, et al: The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 1997; 120:259-267
180. Szabo C: The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996; 6:79-88
181. Szabo C, Billiar TR: Novel roles of nitric oxide in hemorrhagic shock. Shock 1999; 12:1-9
182. Szabo A, Hake P, Salzman AL, et al: Beneficial effects of mercaptoethylguanidine, an inhibitor of the inducible isoform of nitric oxide synthase and a scavenger of peroxynitrite, in a porcine model of delayed hemorrhagic shock. Crit Care Med 1999; 27: 1343-1350
183. Radi R, Beckman JS, Bush KM, et al: Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288:481-487
184. Hogg N, Darley-Usmar VM, Graham A, et al: Peroxynitrite and atherosclerosis. Biochem Soc Trans 1993; 21:358-362
185. Moore KP, Darley-Usmar V, Morrow J, et al: Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ Res 1995; 77: 335-341
186. Patel RP, Diczfalusy U, Dzeletovic S, et al: Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. J Lipid Res 1996; 37:2361-2371
187. Shi H, Noguchi N, Xu Y, et al: Formation of phospholipid hydroperoxides and its inhibition by alpha-tocopherol in rat brain synaptosomes induced by peroxynitrite. Biochem Biophys Res Commun 1999; 257:651-656
188. Smith KJ, Kapoor R, Felts PA: Demyelination: The role of reactive oxygen and nitrogen species. Brain Pathol 1999; 9:69-92
189. van der Veen RC, Roberts LJ: Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids. J Neuroimmunol 1999; 95:1-7
190. Wen Y, Scott S, Liu Y, et al: Evidence that angiotensin II and lipoxygenase products activate c-Jun NH2-terminal kinase. Circ Res 1997; 81:651-655
191. Arteel GE, Briviba K, Sies H: Protection against peroxynitrite. FEBS Lett 1999; 445: 226-230
192. Cuzzocrea S, Zingarelli B, O'Connor M, et al: Effect of L-buthionine-(S,R)-sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite- and endotoxic shock-induced vascular failure. Br J Phamacol 1998; 123:525-537
193. Cuzzocrea S, Costantino G, Zingarelli B, et al: The protective role of endogenous glutathione in carrageenan-induced pleurisy in the rat. Eur J Pharmacol 1999; 372: 187-197
194. Marshall KA, Reist M, Jenner P, et al: The neuronal toxicity of sulfite plus peroxynitrite is enhanced by glutathione depletion: Implications for
195. Berendji D, Kolb-Bachofen V, Meyer KL, et al: Nitric oxide mediates intracytoplasmic and intranuclear zinc release. FEBS Lett 1997; 405:37-41
196. Kroncke KD, Kolb-Bachofen V: Measurement of nitric oxide-mediated effects on zinc homeostasis and zinc finger transcription factors. Methods Enzymol 1999; 301: 126-135
197. Wink DA, Laval J: The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo. Carcinogenesis 1994; 15:2125-2129
198. Viner RI, Williams TD, Schoneich C: Peroxynitrite Modification of Protein Thiols: Oxidation, Nitrosylation, and S-Glutathiolation of Functionally Important Cysteine Residue(s) in the Sarcoplasmic Reticulum Ca-ATPase. Biochemistry 1999; 38: 12408-12415
199. Lizasoain I, Moro MA, Knowles RG, et al: Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J 1996; 314:877-880
200. Szabo C, Day BJ, Salzman AL: Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger. FEBS Lett 1996; 381:82-86
201. Bolanos JP, Heales SJ, Land JM, et al: Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J Neurochem 1995; 64:1965-1972
202. Cassina A, Radi R: Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996; 328:309-316
203. Radi R, Rodriguez M, Castro L, et al: Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 1994; 308:89-95
204. Hausladen A, Fridovich I: Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 1994; 269: 29405-29408
205. Castro L, Rodriguez M, Radi R: Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem 1994; 269:29409-29415
206. Cheung PY, Danial H, Jong J, et al: Thiols protect the inhibition of myocardial aconitase by peroxynitrite. Arch Biochem Biophys 1998; 350:104-108
207. Packer MA, Porteous CM, Murphy MP: Superoxide production by mitochondria in the presence of nitric oxide forms peroxynitrite. Biochem Mol Biol Int 1996; 40:527-534
208. MacMillan-Crow LA, Crow JP, Kerby JD, et al: Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci U S A 1996; 93:11853-11858
209. Szabó C, O'Connor M, Salzman AL: Endogenously produced peroxynitrite induces the oxidation of mitochondrial and nuclear proteins in immunostimulated macrophages. FEBS Lett 1997; 409:147-150
210. Gadelha FR, Thomson L, Fagian MM, et al: Ca2+-independent permeabilization of the inner mitochondrial membrane by peroxynitrite is mediated by membrane protein thiol cross-linking and lipid peroxidation. Arch Biochem Biophys 1997; 345:243-250
211. Packer MA, Scarlett JL, Martin SW, et al: Induction of the mitochondrial permeability transition by peroxynitrite. Biochem Soc Trans 1997; 25:909-914
212. Packer MA, Murphy MP: Peroxynitrite causes calcium efflux from mitochondria which is prevented by cyclosporin A. FEBS Lett 1994; 345:237-240
213. Chakraborti T, Das S, Mondal M, et al: Oxidant, mitochondria and calcium: An overview. Cell Signal 1999; 11:77-85
214. 2+ and peroxynitrite and is responsible for Ca(2+)-induced inhibition of substrate oxidation. Biochim Biophys Acta 1999; 1453:41-48
215. Heales SJ, Bolanos JP, Stewart VC, et al: Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1999; 1410: 215-228
216. Ishida H, Genka C, Hirota Y, et al: Distinct roles of peroxynitrite and hydroxyl radical in triggering stunned myocardium-like impairment of cardiac myocytes in vitro. Mol Cell Biochem 1999; 198:31-38
217. Xie YW, Kaminski PM, Wolin MS: Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ Res 1998; 82:891-897
218. Szabó C: Role of poly(ADP-ribose) synthetase activation in the suppression of cellular energetics in response to nitric oxide and peroxynitrite. Biochem Soc Trans 1997; 25:919-924
219. Szabó C, Zingarelli B, O'Connor M, et al: DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A 1996; 93:1753-1758
220. Szabó C, Dawson VL: Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998; 19:287-298
221. Szabó C, Ohshima H: DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1997; 1:373-385
222. Shimabukuro M, Ohneda M, Lee Y, et al: Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest 1997; 100: 290-295
223. Szabó C, Wong H, Bauer P, et al: Regulation of components of the inflamatory response by 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase and pleiotropic modifier of cellular signal pathways. Int J Oncol 1997:1093-1101
224. Thiemermann C, Bowes J, Myint FP, et al: Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA 1997; 94:679-683
225. Zingarelli B, Cuzzocrea S, Zsengeller Z, et al: Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc Res 1997; 36: 205-215
226. Brune B, von Knethen A, Sandau KB: Nitric oxide and its role in apoptosis. Eur J Pharmacol 1998; 351:261-272
227. Albina JE, Cui S, Mateo RB, et al: Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993; 150: 5080-5085
228. Fehsel K, Kroncke KD, Meyer KL, et al: Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 1995; 155: 2858-2865
229. Pinsky DJ, Aji W, Szabolcs M, et al: Nitric oxide triggers programmed cell death (apoptosis) of adult rat ventricular myocytes in culture. Am J Physiol 1999; 277: H1189-H1199
230. Lopez-Collazo E, Mateo J, Miras-Portugal MT, et al: Requirement of nitric oxide and calcium mobilization for the induction of apoptosis in adrenal vascular endothelial cells. FEBS Lett 1997; 413:124-128
231. Kaneto H, Fujii J, Seo HG, et al: Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes 1995; 44: 733-738
232. Messmer UK, Ankarcrona M, Nicotera P, et al: p53 expression in nitric oxide-induced apoptosis. FEBS Lett 1994; 355:23-26
233. Messmer UK, Brune B: Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. Biochem J 1996; 319:299-305
234. Ambs S, Hussain SP, Harris CC: Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 1997; 11: 443-448
235. Glockzin S, von Knethen A, Scheffner M, et al: Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J Biol Chem 1999; 274: 19581-19586
236. Yabuki M, Kariya S, Inai Y, et al: Molecular mechanisms of apoptosis in HL-60 cells induced by a nitric oxide-releasing compound [published erratum appears in Free Radic Res 1997; 27:659]. Free Radic Res 1997; 27:325-335
237. Sandau K, Pfeilschifter J, Brune B: Nitrosative and oxidative stress induced heme oxygenase-1 accumulation in rat mesangial cells. Eur J Pharmacol 1998; 342:77-84
238. Raghuram N, Fortenberry JD, Owens ML, et al: Effects of exogenous nitric oxide and hyperoxia on lung fibroblast viability and DNA fragmentation. Biochem Biophys Res Commun 1999; 262:685-691
239. Virag L, Scott GS, Cuzzocrea S, et al: Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology 1998; 94:345-355
240. Lin KT, Xue JY, Lin MC, et al: Peroxynitrite induces apoptosis of HL-60 cells by activation of a caspase-3 family protease. Am J Physiol 1998; 274:C855-C860
241. Yabuki M, Kariya S, Ishisaka R, et al: Resistance to nitric oxide-mediated apoptosis in HL-60 variant cells is associated with increased activities of Cu,Zn-superoxide dismutase and catalase. Free Radic Biol Med 1999; 26:325-332
242. Keller JN, Kindy MS, Holtsberg FW, et al: Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 1998; 18:687-697
243. Estevez AG, Spear N, Manuel SM, et al: Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J Neurosci 1998; 18: 923-931
244. Kurrer MO, Pakala SV, Hanson HL, et al: Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci U S A 1997; 94:213-218
245. Delaney CA, Tyrberg B, Bouwens L, et al: Sensitivity of human pancreatic islets to peroxynitrite-induced cell dysfunction and death. FEBS Lett 1996; 394:300-306
246. Suarez-Pinzon WL, Szabo C, Rabinovitch A: Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet beta-cells. Diabetes 1997; 46:907-911
247. Fortenberry JD, Owens ML, Brown MR, et al: Exogenous nitric oxide enhances neutrophil cell death and DNA fragmentation. Am J Respir Cell Mol Biol 1998; 18:421-428
248. Bosca L, Hortelano S: Mechanisms of nitric oxide-dependent apoptosis: Involvement of mitochondrial mediators. Cell Signal 1999; 11:239-244
249. Koglin J, Granville DJ, Glysing-Jensen T, et al: Attenuated acute cardiac rejection in NOS2 -/-recipients correlates with reduced apoptosis. Circulation 1999; 99:836-842
250. Szabolcs MJ, Ravalli S, Minanov O, et al: Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplant 1998; 65: 804-812
251. Sandoval M, Zhang XJ, Liu X, et al: Peroxynitrite-induced apoptosis in T84 and RAW 264.7 cells: Attenuation by L-ascorbic acid. Free Radic Biol Med 1997; 22: 489-495
252. Bolanos JP, Almeida A, Stewart V, et al: Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem 1997; 68:2227-2240
253. Bonfoco E, Krainc D, Ankarcrona M, et al: Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci U S A 1995; 92: 7162-7166
254. Leist M, Single B, Naumann H, et al: Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis. Exp Cell Res 1999; 249:396-403
255. Genaro AM, Hortelano S, Alvarez A, et al: Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 1995; 95: 1884-1890
256. Kim YM, Chung HT, Kim SS, et al: Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J Neurosci 1999; 19:6740-6747
257. Haendeler J, Weiland U, Zeiher AM,et al: Effects of redox-related congeners of NO on apoptosis and caspase-3 activity. Nitric Oxide 1997; 1:282-293
258. Li J, Bombeck CA, Yang S, et al: Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J Biol Chem 1999; 274:17325-17333
259. Mohr S, Zech B, Lapetina EG, et al: Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem Biophys Res Commun 1997; 238:387-391
260. Stefanelli C, Pignatti C, Tantini B, et al: Nitric oxide can function as either a killer molecule or an antiapoptotic effector in cardiomyocytes. Biochim Biophys Acta 1999; 1450:406-413
261. Hewlett CE, Hutchison JS, Veinot JP, et al: Inhaled nitric oxide protects against hyperoxia-induced apoptosis in rat lungs. Am J Physiol 1999; 277:L596-L605
262. Furuke K, Burd PR, Horvath-Arcidiacono JA, et al: Human NK cells express endothelial nitric oxide synthase, and nitric oxide protects them from activation-induced cell death by regulating expression of TNF-alpha. J Immunol 1999; 163:1473-1480
263. Foresti R, Sarathchandra P, Clark JE, et al: Peroxynitrite induces haem oxygenase-1 in vascular endothelial cells: A link to apoptosis. Biochem J 1999; 339:729-736
264. Madesh M, Ramachandran A, Balasubramanian KA: Nitric oxide prevents anoxia-induced apoptosis in colonic HT29 cells. Arch Biochem Biophys 1999; 366:240-248
265. Ischiropoulos H: Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998; 356:1-11
266. Eiserich JP, Cross CE, Jones AD, et al: Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem 1996; 271:19199-19208
267. van der Vliet A, Eiserich JP, Halliwell B, et al: Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 1997; 272:7617-7625
268. Beckman JS, Carson M, Smith CD, et al: ALS, SOD and peroxynitrite. Nature 1993; 364:584
269. Boota A, Zar H, Kim YM, et al: IL-1 beta stimulates superoxide and delayed peroxynitrite production by pulmonary vascular smooth muscle cells. Am J Physiol 1996; 271:L932-L938
270. Crow JP, Ye YZ, Strong M, et al: Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L. J Neurochem 1997; 69:1945-1953
271. Crow JP, Sampson JB, Zhuang Y, et al: Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J Neurochem 1997; 69:1936-1944
272. van der Vliet A, Eiserich JP, Shigenaga MK, et al: Reactive nitrogen species and tyrosine nitration in the respiratory tract: Epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med 1999; 160:1-9
273. Ara J, Przedborski S, Naini AB, et al: Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc Natl Acad Sci U S A 1998; 95:7659-7663
274. Cow AJ, Duran D, Malcolm S, et al: Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett 1996; 385:63-66
275. Kong SK, Yim MB, Stadtman ER, et al: Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: Lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide. Proc Natl Acad Sci U S A 1996; 93:3377-3382
276. Southan GJ, Szabo C: Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1996; 51:383-394
277. Cobb JP, Hotchkiss RS, Swanson PE, et al: Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. Surgery 1999; 126:438-442
278. Karupiah G, Xie QW, Buller RM, et al: Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 1993; 261:1445-1448